Skip to main content

Table 3 Comparison of CA125 levels before and after treatment between the two groups (x ̅± s)

From: Observation of the therapeutic effect of apatinib in advanced platinum-resistant recurrent epithelial ovarian cancer

Group

CA125 changes

 

Before treatment

After treatment

P

Apatinib group

929.03 ± 1694.71

408 ± 565.50

0.032

Control group

700.52 ± 1332.16

1091.084 ± 1928.68

0.006

P

0.446

0.005

 
Back to article page

Journal of Ovarian Research

ISSN: 1757-2215

Contact us